Univec Inc (UNVC)

[Euripides90]

Float not updated since 2011+STOP SIGN; O/S=reasonable,but A/S-dilution potential=HIGH; no quarterly reports or ANY filings since 2010-11, hmmm....


Authorized Shares 5,000,000,000 a/o Oct 19, 2017
Outstanding Shares 1,179,023,522 a/o Oct 19, 2017
-Restricted 126,898,642 a/o Oct 19, 2017
-Unrestricted 1,052,124,880 a/o Oct 19, 2017
Held at DTC 1,038,777,550 a/o Oct 19, 2017
Float 221,867,522 a/o Dec 06, 2011

https://www.otcmarkets.com/stock/UNVC/filings

latest news 2012: did promo even come to pass?
The "Nicotine replacement patch" they finished R & D for?
https://www.otcmarkets.com/stock/UNVC/news/UNIVEC-announces-completion-of-R-D-for-Nicotine-Replacement-Patch?id=48935&b=y

https://www.otcmarkets.com/stock/UNVC/news

Then suddenly 5 years later, Dalton announces a cannabis-related partnership: why choose THIS particular company?
Is this being promo'd somewhere?
Based on convo's with Dalton?
He's promising to get Current?
What's he been doing last 5 years?

https://www.otcmarkets.com/stock/UNVC/news

AGRiMED Industries Announces Cannabis Oil Partnership with Univec.

GREENE COUNTY, Pa., Oct. 2, 2017 /PRNewswire/ -- AGRiMED, which owns one of the twelve licenses authorized by the Commonwealth of Pennsylvania to grow and process medical cannabis, today announced a unique and innovative partnership with Univec, Inc (UNVC), a specialty pharmaceutical company to manufacture and distribute its medical cannabis transdermal patch for treatment and relief of approved medical conditions. A transdermal patch adheres or sticks to the skin and delivers a specific dose of medication through the skin and into the bloodstream.

AGRiMED Industries Chief Executive Officer (CEO) Sterling Crockett said, "Today's announcement is consistent with our philosophy of connecting those in need with innovations that heal cleanly, comfortably and sustainably." He added, "We are excited about working with Univec and look forward to sharing the benefits of this partnership with the people of Pennsylvania and beyond."

Dr. David Dalton, Univec's CEO said "Combining Univec's medical and pharmaceutical expertise with AGRiMED Industries' innovative approach to the cannabis marketplace and commitment to its patient focused services makes for a very powerful partnership to expand the treatment options available to the medical community."